The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFR alpha-mAb treatment in rheumatoid arthritis patients
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | Clinical and Experimental Rheumatology |
| Volume | 37 |
| Issue number | 1 |
| ISSN | 0392-856X |
| Publication status | Published - 2019 |
- macrophages, biomarker, citrullination, vimentin, rheumatoid arthritis, autoimmunity, anti-GM-CSF, matrix metalloproteinase
Research areas
Links
- https://www.clinexprheumatol.org/abstract.asp?a=12587
Final published version
ID: 223822097